Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044235770> ?p ?o ?g. }
- W2044235770 endingPage "428" @default.
- W2044235770 startingPage "420" @default.
- W2044235770 abstract "Isolated limb perfusion (ILP) with tumor necrosis factor-alpha (TNF) and melphalan for advanced extremity malignancies achieves significant complete response rates. To study molecular mechanisms underlying this response, a nude rat ILP model with a human melanoma xenograft was developed.NIH1286 human melanoma was grown subcutaneously in the hind limb of nude rats. Anesthetized rats underwent a 10-minute ILP via femoral vessels with hetastarch, heparin, and melphalan, TNF, or TNF plus melphalan. The tumors and ulcers were measured and viable tumor area was calculated. Post-ILP tumors were analyzed by electron microscopy for vascular damage and also by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry (LC/APCI/MS/MS) for free melphalan levels. Colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-dephenyltetrazolium bromide (MTT) assays were performed on NIH1286 cells and human dermal microvascular endothelial cells (HDMVEC) to test for direct cytotoxicity to TNF and melphalan. Post-ILP tumors sections were also examined by electron microscopy.The mean maximal decrease in viable tumor area after ILP for control, TNF, melphalan, and TNF + melphalan groups were 0%, 22 +/- 13%, 61 +/- 14%, and 100 +/- 0%, respectively. LC/APCI/MS/MS revealed no difference in the free tumor melphalan concentration between melphalan alone and TNF + melphalan groups. The percent cytotoxicity in MTT assays using TNF, melphalan, and TNF + melphalan against NIH1286 were 0%, 51-59%, and 74-81%, respectively, and against HDMVEC were 28%, 16-23%, and 6-13%, respectively. Electron microscopic analyses showed that addition of TNF to the perfusate caused erythrostasis in tumor blood vessels.We developed a human melanoma nude rat ILP model with tumor responses very similar to the human ILP trials. This model will allow further investigation of the synergistic mechanism of TNF and melphalan in human melanoma in a preclinical setting, and extension of this study to current clinical trials." @default.
- W2044235770 created "2016-06-24" @default.
- W2044235770 creator A5007552954 @default.
- W2044235770 creator A5027531484 @default.
- W2044235770 creator A5031781569 @default.
- W2044235770 creator A5039235763 @default.
- W2044235770 creator A5050237385 @default.
- W2044235770 creator A5077902939 @default.
- W2044235770 creator A5079384190 @default.
- W2044235770 date "2003-04-01" @default.
- W2044235770 modified "2023-10-16" @default.
- W2044235770 title "A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan" @default.
- W2044235770 cites W1889451488 @default.
- W2044235770 cites W1932474041 @default.
- W2044235770 cites W1962681190 @default.
- W2044235770 cites W1990151073 @default.
- W2044235770 cites W1992644466 @default.
- W2044235770 cites W2024928333 @default.
- W2044235770 cites W2028573799 @default.
- W2044235770 cites W2033005592 @default.
- W2044235770 cites W2043560895 @default.
- W2044235770 cites W2051379819 @default.
- W2044235770 cites W2073442604 @default.
- W2044235770 cites W2087650119 @default.
- W2044235770 cites W2090926682 @default.
- W2044235770 cites W2117184471 @default.
- W2044235770 cites W2120406858 @default.
- W2044235770 cites W2123927174 @default.
- W2044235770 cites W2128569116 @default.
- W2044235770 cites W2128696371 @default.
- W2044235770 cites W2131887263 @default.
- W2044235770 cites W2223024204 @default.
- W2044235770 cites W2336324298 @default.
- W2044235770 doi "https://doi.org/10.1067/msy.2003.113" @default.
- W2044235770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12717360" @default.
- W2044235770 hasPublicationYear "2003" @default.
- W2044235770 type Work @default.
- W2044235770 sameAs 2044235770 @default.
- W2044235770 citedByCount "20" @default.
- W2044235770 countsByYear W20442357702012 @default.
- W2044235770 countsByYear W20442357702016 @default.
- W2044235770 countsByYear W20442357702017 @default.
- W2044235770 crossrefType "journal-article" @default.
- W2044235770 hasAuthorship W2044235770A5007552954 @default.
- W2044235770 hasAuthorship W2044235770A5027531484 @default.
- W2044235770 hasAuthorship W2044235770A5031781569 @default.
- W2044235770 hasAuthorship W2044235770A5039235763 @default.
- W2044235770 hasAuthorship W2044235770A5050237385 @default.
- W2044235770 hasAuthorship W2044235770A5077902939 @default.
- W2044235770 hasAuthorship W2044235770A5079384190 @default.
- W2044235770 hasConcept C109316439 @default.
- W2044235770 hasConcept C126322002 @default.
- W2044235770 hasConcept C126894567 @default.
- W2044235770 hasConcept C142724271 @default.
- W2044235770 hasConcept C146957229 @default.
- W2044235770 hasConcept C17991360 @default.
- W2044235770 hasConcept C185592680 @default.
- W2044235770 hasConcept C202751555 @default.
- W2044235770 hasConcept C2776694085 @default.
- W2044235770 hasConcept C2777658100 @default.
- W2044235770 hasConcept C2778684742 @default.
- W2044235770 hasConcept C502942594 @default.
- W2044235770 hasConcept C55493867 @default.
- W2044235770 hasConcept C71924100 @default.
- W2044235770 hasConcept C98274493 @default.
- W2044235770 hasConceptScore W2044235770C109316439 @default.
- W2044235770 hasConceptScore W2044235770C126322002 @default.
- W2044235770 hasConceptScore W2044235770C126894567 @default.
- W2044235770 hasConceptScore W2044235770C142724271 @default.
- W2044235770 hasConceptScore W2044235770C146957229 @default.
- W2044235770 hasConceptScore W2044235770C17991360 @default.
- W2044235770 hasConceptScore W2044235770C185592680 @default.
- W2044235770 hasConceptScore W2044235770C202751555 @default.
- W2044235770 hasConceptScore W2044235770C2776694085 @default.
- W2044235770 hasConceptScore W2044235770C2777658100 @default.
- W2044235770 hasConceptScore W2044235770C2778684742 @default.
- W2044235770 hasConceptScore W2044235770C502942594 @default.
- W2044235770 hasConceptScore W2044235770C55493867 @default.
- W2044235770 hasConceptScore W2044235770C71924100 @default.
- W2044235770 hasConceptScore W2044235770C98274493 @default.
- W2044235770 hasIssue "4" @default.
- W2044235770 hasLocation W20442357701 @default.
- W2044235770 hasLocation W20442357702 @default.
- W2044235770 hasOpenAccess W2044235770 @default.
- W2044235770 hasPrimaryLocation W20442357701 @default.
- W2044235770 hasRelatedWork W128115444 @default.
- W2044235770 hasRelatedWork W1969505757 @default.
- W2044235770 hasRelatedWork W2020844025 @default.
- W2044235770 hasRelatedWork W2086094746 @default.
- W2044235770 hasRelatedWork W2094845580 @default.
- W2044235770 hasRelatedWork W2399161820 @default.
- W2044235770 hasRelatedWork W2410050620 @default.
- W2044235770 hasRelatedWork W2415636878 @default.
- W2044235770 hasRelatedWork W2416567523 @default.
- W2044235770 hasRelatedWork W2997632039 @default.
- W2044235770 hasVolume "133" @default.
- W2044235770 isParatext "false" @default.
- W2044235770 isRetracted "false" @default.